BioSpace News Archive

Drug Development

Global Strategic Partners Merck KGaA, Darmstadt, Germany, And Pfizer nitiate Phase III Study With Avelumab* In Patients With Stage IIIb/IV Non-Small Cell Lung Cancer

April 20, 2015
·
11 min read
Drug Development

Early Findings With KEYTRUDA (Pembrolizumab), Merck & Co.’s Anti-PD-1 Therapy, In Patients With Advanced Pleural Mesothelioma Presented At American Association for Cancer Research Annual Meeting

April 20, 2015
·
12 min read
Drug Development

Anika Therapeutics’ Cingal 13-02 Study Meets Primary Endpoint

April 20, 2015
·
6 min read
Drug Development

Pluristem Therapeutics’s Clinical Advisory Board Prepares Phase II Clinical Trials In Critical Limb Ischemia In Europe And Japan

April 20, 2015
·
4 min read
Drug Development

MediWound Initiates U.S. Phase 3 Trial With NexoBrid To Treat Severe Burns

April 20, 2015
·
5 min read
Business

NeoStem, Inc. Announces Expanded Cell Therapy Manufacturing Relationship With Kite Pharma

April 20, 2015
·
4 min read
Business

Lori Rafield, Ph.D. Appointed Permanent CEO Of diaDexus

April 20, 2015
·
3 min read
Drug Development

Bionomics Limited Initiates Phase II Clinical Trial Of BNC210 For Treatment Of Anxiety

April 20, 2015
·
7 min read
Drug Development

ChemoCentryx, Inc. Initiates Clinical Trial Of CCX872, Its Next-Generation, Orally Administered CCR2 Inhibitor, In Pancreatic Cancer

April 20, 2015
·
7 min read
Drug Development

Rexahn Pharmaceuticals, Inc. Identifies RX-3117 Biomarker & Presents Data At The 2015 AACR Annual Meeting

April 20, 2015
·
5 min read